Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
SURC (Symptom and Urgent Review Clinic) in oncology practice: clinical utility and application in a regional setting-a retrospective observational study.
Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the benefit of the new 'SURC' model, allowing patients having systemic anti-cancer therapy (SACT) to be seen acutely for assessment of adverse events, as well as scheduled early review in their treatment course. It also assessed the effect of the COVID-19 pandemic on this service.
methodsData was collected prospectively between 2020 and 2023 and then analysed retrospectively. The clinic was implemented at Ballarat Regional Integrated Cancer Centre (BRICC). It also included two outreach sites: Primary outcomes were the number of interactions by patients with SURC; secondary outcomes included the number of admissions, type of cancer involved, and reasons for contacting SURC.
resultsThis study demonstrated benefit for patients with cancer from a regional area who presented with acute complications of their treatment. Presentations requiring hospital admissions and further assessment in ED were lower compared to the pre-SURC period, with most patients being treated comprehensively in the SURC environment. The study demonstrated the utility of early SACT review as there was a decrease in the number of treatment disruptions due to early recognition of complications of each patient's regimen. There was also a gradual increase in patient presentations to the clinic during the duration of the study, reflecting the growing awareness and confidence in the service from both healthcare providers and patients alike.
conclusionThis study demonstrates the benefit of the novel SURC model to patients living in regional areas with cancer who either develop acute complications or are routinely reviewed early during their course of treatment. Although this study was limited to only one public health service provider, we feel this new proactive paradigm for acute cancer care will become increasingly adopted across Australia, given its proven ability to look after patients undergoing SACT more efficiently in addition to reducing hospital admissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.